Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CYCN stock hub

Cyclerion Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CYCNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CYCN

In the news

Latest news · CYCN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-39.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-34.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CYCN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001755237
Company name	Cyclerion Therapeutics, Inc.
Country	United States
Country code	US
Cusip	23255M105
Employees	1
Employees Change	-15%
Employees Change Percent	-93.75
Enterprise value	$9.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US23255M2044
Last refreshed	2026-05-10
Market cap	$13.1M
Market cap category	Nano-Cap
Price	$3.1
Price currency	USD
Rev Per Employee	2,074,000x
Sector	Healthcare
Sic	2834
Symbol	CYCN
Website	https://www.cyclerion.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.93%
EV/Sales	4.75x
FCF yield	-25.3%
P/B ratio	1.3x
P/S ratio	6.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-239.78%
Gross margin	53.76%
Gross Profit	$1.1M
Gross Profit Growth	-34.95%
Gross Profit Growth Q	-71.09%
Net Income	$-3.5M
Net Income Growth Years	0%
Pretax Margin	-170.11%
Profit Margin	-170.11%
Profit Per Employee	$-3.5M
ROA	-31.78
Roa5y	-31.74
ROCE	-54.74
ROE	-39.34
Roe5y	-68.72
ROIC	-34.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-9.63%
Cagr3y	-18.17%
Cagr5y	-43.79%
EPS Growth Years	6
Revenue Growth	3.7x
Revenue Growth Q	-43.25x
Revenue Growth Years	1x
Revenue Growth3 Y	91.14x
Revenue Growth5 Y	-2.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.21
Assets	$10M
Cash	$3.2M
Current Assets	$4.6M
Current Liabilities	$900,000
Equity	$9.1M
Liabilities	$900,000
Long Term Assets	$5.4M
Long Term Liabilities	$0
Net Cash	$3.2M
Net Cash By Market Cap	$24.73
Net Cash Growth	0.25%
Net Debt Equity	$-0.36
Tangible Book Value	$9.1M
Tangible Book Value Per Share	$2.38
WACC	14.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.15
Net Working Capital	$495,000
Quick ratio	4.71
Working Capital	$3.7M
Working Capital Turnover	$0.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.33%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-9.62%
200-day SMA	2.07
3Y total return	-45.21%
50-day SMA	2.5
50-day SMA vs 200-day SMA	50over200
5Y total return	-94.38%
All Time High	457
All Time High Change	-99.32%
All Time High Date	2019-04-01
All Time Low	1.03
All Time Low Change	201.85%
All Time Low Date	2026-02-09
ATR	0.33
Beta	1.81
Beta1y	4.34
Beta2y	1.43
Ch YTD	144.1
High	3.16
High52	8.48
High52 Date	2026-04-01
High52ch	-63.44%
Low	3.07
Low52	1.03
Low52 Date	2026-02-09
Low52ch	201.85%
Ma50ch	24.15%
Premarket Change Percent	-0.95
Premarket Price	$3.12
Premarket Volume	233
Price vs 200-day SMA	49.9%
RSI	52.8
RSI Monthly	40.66
RSI Weekly	67.64
Sharpe ratio	0.64x
Sortino ratio	2.93
Total Return	-26.33%
Tr YTD	144.1
Tr1m	-10.92%
Tr1w	-4.91%
Tr3m	181.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-5M
Operating margin	-239.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,490,494%
Float Percent	82.59%
Shares Insiders	17.41%
Shares Institutions	33.82%
Shares Out	4,226,236
Shares Qo Q	18.17%
Shares Yo Y	26.33%
Short Float	7.66%
Short Ratio	0.02
Short Shares	6.33

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.8M
Average Volume	148,900.35x
Bv Per Share	2.38
Ch1m	-10.92
Ch1w	-4.91
Ch1y	-9.62
Ch3m	181.8
Ch3y	-45.21
Ch5y	-94.38
Ch6m	91.12
Change	-1.59%
Change From Open	-1.59
Close	3.15
Days Gap	0
Dollar Volume	171,469.9
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-5M
EPS	$-1.11
F Score	2
FCF	$-3.3M
FCF EV Yield	-33.61x
FCF Per Share	$-0.78
Financing CF	3,322,000
Fiscal Year End	December
Founded	2,018
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Date	2023-05-16
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	1.91
Ma150ch	61.96%
Ma20	3.09
Ma20ch	0.23%
Net CF	8,000
Next Earnings Date	2026-05-22
Open	3.15
Optionable	No
Position In Range	38.89
Post Close	3.1
Postmarket Change Percent	-2.58
Postmarket Price	$3.02
Pre Close	3.15
Price Date	2026-05-08
Ptbv Ratio	1.44
Relative Volume	0.37x
Revenue	2,074,000x
SBC By Revenue	21.26x
Share Based Comp	441,000
Tr6m	91.12%
Us State	Massachusetts
Volume	55,312.9
Z Score	-33.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CYCN pay a dividend?

Capital-return profile for this ticker.

Performance

CYCN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CYCN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.8%

Float: +82.6% of shares outstanding

Insider ownership

+17.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CYCN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.8

Neutral momentum band

Price vs 200-day MA

+49.9%

50/200-day relationship not available

Beta (5Y)

1.81

More volatile than the market

Sharpe ratio

0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CYCN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CYCN stock rating?

Cyclerion Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CYCN analysis?

The full report lives at /stocks/CYCN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CYCN?

The latest report frames CYCN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CYCN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.